Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-068004
Filing Date
2021-03-04
Accepted
2021-03-03 20:01:41
Documents
11
Effectiveness Date
2021-03-04

Document Format Files

Seq Description Document Type Size
1 S-3ASR d124843ds3asr.htm S-3ASR 577428
2 EX-1.2 d124843dex12.htm EX-1.2 210326
3 EX-5.1 d124843dex51.htm EX-5.1 20378
4 EX-5.2 d124843dex52.htm EX-5.2 28038
5 EX-23.2 d124843dex232.htm EX-23.2 1405
6 GRAPHIC g124843dsp001.jpg GRAPHIC 3741
7 GRAPHIC g124843dsp1a.jpg GRAPHIC 3716
8 GRAPHIC g124843g01t12.jpg GRAPHIC 35978
9 GRAPHIC g124843g02u25.jpg GRAPHIC 42274
10 GRAPHIC g124843g29y58.jpg GRAPHIC 45217
11 GRAPHIC g124843g96q94.jpg GRAPHIC 75151
  Complete submission text file 0001193125-21-068004.txt   1113745
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-253851 | Film No.: 21711844
SIC: 2834 Pharmaceutical Preparations